首页 > 最新文献

Pharmacology, Toxicology and Biomedical Reports最新文献

英文 中文
Infection Control Pharmacist: A New Initiative Project in the Kingdom of Saudi Arabia 感染控制药剂师:沙特阿拉伯王国的一个新倡议项目
Pub Date : 2021-09-24 DOI: 10.5530/PTB.2021.7.8
Y. Alomi, Anhar Alyousef
Objectives: To declare the Infection control pharmacist as new initiatives in the Kingdom of Saudi Arabia. Methods: It is a new initiative project drove by national and international Infection control regulations and guidelines. The projects are formulated from the global business model, pharmacy project guidelines and professional project management elements. The initial project followed the project management professionals, including the initial phase, the planning phase, the execution phase and the monitoring and controlling phase. Results: The vision, mission and goals of the Infection control pharmacist are explored. The services had various benefits, including clinical and economical, on patients, as illustrated in the review. The continuous of the project revised by the risk management model description. Moreover, the monitoring and controlling of the services as declared. The transition to operation project through closing project stage explored in the analysis. Conclusion: The Infection control pharmacist is a new initiative and part of the clinical pharmacy specialties and pharmacy infection control services. The Infection control pharmacist meet the demand of pharmacy infection control, prevent infection control related problems and contribute during epidemic or pandemic and medical disaster; it is highly suggested to implement in Saudi Arabia
目的:宣布感染控制药剂师在沙特阿拉伯王国的新举措。方法:这是在国家和国际感染控制法规和指南的推动下开展的一项新举措。项目从全球商业模式、药学项目指南和专业项目管理要素制定。项目初期跟随项目管理专业人员,包括初始阶段、计划阶段、执行阶段和监控阶段。结果:探讨了感染控制药师的愿景、使命和目标。这些服务有各种各样的好处,包括临床和经济,对病人来说,在审查中说明。由风险管理模型描述修订的项目的连续性。此外,按照声明对服务进行监视和控制。在分析中探讨了从项目收尾阶段到运营阶段的过渡。结论:感染控制药师是临床药学专业和药学感染控制服务的一项新举措。感染控制药师满足药学感染控制需求,预防感染控制相关问题,在疫情或大流行、医疗灾难中发挥作用;强烈建议在沙特阿拉伯实施
{"title":"Infection Control Pharmacist: A New Initiative Project in the Kingdom of Saudi Arabia","authors":"Y. Alomi, Anhar Alyousef","doi":"10.5530/PTB.2021.7.8","DOIUrl":"https://doi.org/10.5530/PTB.2021.7.8","url":null,"abstract":"Objectives: To declare the Infection control pharmacist as new initiatives in the Kingdom of Saudi Arabia. Methods: It is a new initiative project drove by national and international Infection control regulations and guidelines. The projects are formulated from the global business model, pharmacy project guidelines and professional project management elements. The initial project followed the project management professionals, including the initial phase, the planning phase, the execution phase and the monitoring and controlling phase. Results: The vision, mission and goals of the Infection control pharmacist are explored. The services had various benefits, including clinical and economical, on patients, as illustrated in the review. The continuous of the project revised by the risk management model description. Moreover, the monitoring and controlling of the services as declared. The transition to operation project through closing project stage explored in the analysis. Conclusion: The Infection control pharmacist is a new initiative and part of the clinical pharmacy specialties and pharmacy infection control services. The Infection control pharmacist meet the demand of pharmacy infection control, prevent infection control related problems and contribute during epidemic or pandemic and medical disaster; it is highly suggested to implement in Saudi Arabia","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131759038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Evidence-based Drug Dentistry Resource: New Initiative Project in Saudi Arabia 循证药物牙科资源:沙特阿拉伯的新倡议项目
Pub Date : 2021-09-24 DOI: 10.5530/ptb.2021.7.12
Y. Alomi, H. Aljohani, Aroub Abdullah Albatel
{"title":"Evidence-based Drug Dentistry Resource: New Initiative Project in Saudi Arabia","authors":"Y. Alomi, H. Aljohani, Aroub Abdullah Albatel","doi":"10.5530/ptb.2021.7.12","DOIUrl":"https://doi.org/10.5530/ptb.2021.7.12","url":null,"abstract":"","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132016709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
National Survey of Clinical Pharmacy Practice in Saudi Arabia-2017-2018: Workload Documentation 沙特阿拉伯临床药学实践全国调查-2017-2018:工作量文件
Pub Date : 2020-06-04 DOI: 10.5530/PTB.2020.6.16
Y. Alomi, Fatimah Al-Doughan, Sultan Mohammed Al-Jarallah, Y. Ibrahim, A. M. Alragas, Norah Omar Bin Haidarah
Yousef Ahmed Alomi*, BSc. Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE, Critical Care Clinical Pharmacists, TPN Clinical Pharmacist, Freelancer Business Planner, Content Editor and Data Analyst, Riyadh, Saudi Arabia. Fatimah Al-Doughan, PharmD, Lecturer College of Pharmacy, Pharmacy Practice Department King Faisal University, Alahssa, Saudi Arabia. Sultan Mohammed Al-Jarallah, Head, Ambulatory Care Pharmacy, Oncology and Hematology Clinical Pharmacist, Pharmaceutical Care Department, Security Forces Hospital, Riyadh, Saudi Araia. Yasir Ahmed Ibrahim, PharmD, Head of Pharmacy Practice Department Pharmacy Practice Department College of Clinical Pharmacy, King Faisal University, Alahssa, Saudi Arabia. Adel Mehmas Alragas, Bsc. Pharm, Staff Pharmacist Pharmacy Department Medical City King Saud University, Riyadh, Saudi Arabia. Norah Omar Bin Haidarah, PharmD, Pharmacy Staff Outpatient pharmacy Dr Sulaiman Al-habib Hopsital, Riyadh, Saudi Arabia.
Yousef Ahmed Alomi*,理学学士。制药,MSc。临床药剂师,BCPS, BCNSP, DiBA, CDE,重症监护临床药剂师,TPN临床药剂师,自由职业者业务规划师,内容编辑和数据分析师,沙特阿拉伯利雅得。Fatimah Al-Doughan,药学博士,沙特阿拉伯阿拉赫萨费萨尔国王大学药学院药学实践系讲师。苏丹·穆罕默德·阿尔-贾拉拉,主任,流动护理药房,肿瘤和血液临床药剂师,药学护理部,安全部队医院,利雅得,沙特阿拉伯。亚西尔·艾哈迈德·易卜拉欣,药学博士,药学实践部主任,沙特阿拉伯阿拉赫萨费萨尔国王大学临床药学学院。阿德尔·穆罕默德·阿拉加斯,理学士。医药城沙特国王大学,利雅得,沙特阿拉伯。Norah Omar Bin Haidarah,药学博士,药学工作人员门诊药房Sulaiman Al-habib医院,利雅得,沙特阿拉伯。
{"title":"National Survey of Clinical Pharmacy Practice in Saudi Arabia-2017-2018: Workload Documentation","authors":"Y. Alomi, Fatimah Al-Doughan, Sultan Mohammed Al-Jarallah, Y. Ibrahim, A. M. Alragas, Norah Omar Bin Haidarah","doi":"10.5530/PTB.2020.6.16","DOIUrl":"https://doi.org/10.5530/PTB.2020.6.16","url":null,"abstract":"Yousef Ahmed Alomi*, BSc. Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE, Critical Care Clinical Pharmacists, TPN Clinical Pharmacist, Freelancer Business Planner, Content Editor and Data Analyst, Riyadh, Saudi Arabia. Fatimah Al-Doughan, PharmD, Lecturer College of Pharmacy, Pharmacy Practice Department King Faisal University, Alahssa, Saudi Arabia. Sultan Mohammed Al-Jarallah, Head, Ambulatory Care Pharmacy, Oncology and Hematology Clinical Pharmacist, Pharmaceutical Care Department, Security Forces Hospital, Riyadh, Saudi Araia. Yasir Ahmed Ibrahim, PharmD, Head of Pharmacy Practice Department Pharmacy Practice Department College of Clinical Pharmacy, King Faisal University, Alahssa, Saudi Arabia. Adel Mehmas Alragas, Bsc. Pharm, Staff Pharmacist Pharmacy Department Medical City King Saud University, Riyadh, Saudi Arabia. Norah Omar Bin Haidarah, PharmD, Pharmacy Staff Outpatient pharmacy Dr Sulaiman Al-habib Hopsital, Riyadh, Saudi Arabia.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"201 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133953458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability and Validity of Biostatical Analysis used for Pharmacy Research Questionnaire in Saudi Arabia 沙特阿拉伯药学研究问卷生物统计学分析的信度和效度
Pub Date : 2020-06-04 DOI: 10.5530/PTB.2020.6.18
Y. Alomi, Ismail Hassan Amer Abu Rayah
Phone no: +966504417712 E-mail: yalomi@gmail.com ABSTRACT Objectives: To declare reliability and validity of Biostatical Analysis used for Pharmacy Research Survey in Saudi Arabia. Methods: It is a cross-section survey developed by the authors and the research team. It’s based on the updated literature, national and international accreditation standards organizations. The Internal consistency, reliability through inter-rater reliability, item-item coloration, item-total coloration, Split half reliability (Gutmann’s λ6) and McDonald’s ω, Cronbach alpha. The validity contained of face content validity, construct validity through exploratory factorial analysis and confirmatory factor analysis. All analysis had been done through Statistical Package of Social Sciences (SPSS), Statistical Package of Social Sciences-Analysis of Moment Structures (SPSS-Amos) and Jeffrey’s Amazing Statistics Program (JASP). Results: A total of 209 pharmacists responded. The majority of responders were Saudi 185 (88.52%). The among responders were males [108 (61.77%)] and females [101 (48.33%)]. The three tests had been done with reliability of 31 questions. The completed responders (185) (mean ± SD) was 3.236 ± 0.326 and McDonald’s ω, Cronbach alpha and Gutmann’s λ6 were 0.980, 0.980 and 0.990, respectively with CI 95% (0.975-0.983) and inter-item coloration was 0.607, while the item-total coloration >0.53 and McDonald’s ω, Cronbach alpha and Gutmann’s λ6 value if deleted was >0.97. By using Exploratory Factor Analysis (EFA), the Kaiser-Meyer-Olkin Measure of sampling adequacy was 0.966 and Bartlett’s test of sphericity with approximate chi-square was <0.001. The commonalities extraction for all questions was >0.57, the related components were four of all 31 questions in four components as suggested. They were not confirmed by confirmatory with statistically significant (p<0.001) of the factor model, by factor analysis, by scree plot and pathway analysis and fit not with the original survey changed to 3 factor loading. The confirmatory factor index was (0.761), Tucker-Lewis Index (TLI) was (0.737), Goodness of fit index (GFI) was (0.844) and expected cross validation index (ECVI) (9.029). The collinearity of 23 questions was autocorrelation (2.609e -5) with not statistically significant (p=0.951). The majority of 23 question had Enjuone value close to number 1, while 11 questions had condition index more than 30. All of the 23 questions had The Variance inflation factor (VIF) less than 10 except four questions and had tolerance more than 0.1 except four questions. Conclusion: The reliability and validity related to the corrected survey of biostatistics analysts used in pharmaceutical research in the Kingdom of Saudi Arabia were high. The pharmacy practice was properly used in further future research in Saudi Arabia.
摘要目的:申报沙特阿拉伯药学研究调查中使用的生物统计学分析的信度和效度。方法:采用作者与课题组共同开展的横断面调查。它是基于最新的文献,国家和国际认证标准组织。内部一致性、信度通过量表间信度、项目-项目颜色、项目-总体颜色、分裂半信度(Gutmann 's λ6)和McDonald 's ω、Cronbach α。效度包含面部内容效度,通过探索性因子分析和验证性因子分析构建效度。所有的分析都是通过社会科学统计软件包(SPSS),社会科学统计软件包-力矩结构分析(SPSS- amos)和杰弗里的惊人统计程序(JASP)完成的。结果:共有209名药师回复。应答者以沙特185人(88.52%)居多。应答者中男性108人(61.77%),女性101人(48.33%)。这三个测试的可靠性为31个问题。完成应答者185人(平均±SD)为3.236±0.326,McDonald’s ω、Cronbach α和Gutmann’s λ6分别为0.980、0.980和0.990,CI为95%(0.975 ~ 0.983),项目间显色为0.607,项目总显色>0.53,删除后McDonald’s ω、Cronbach α和Gutmann’s λ6值>0.97。经探索性因子分析(EFA), Kaiser-Meyer-Olkin抽样充分性检验为0.966,Bartlett球性近似卡方检验为0.57,4个成分中31个问题中有4个相关成分。因子模型的验证性(p<0.001)、因子分析、筛选图和途径分析均未证实,与原调查改为3因子负荷不吻合。验证性因子指数为(0.761),Tucker-Lewis指数为(0.737),拟合优度指数为(0.844),期望交叉验证指数为(9.029)。23题共线性为自相关(2.609e -5),无统计学意义(p=0.951)。在23个问题中,大多数问题的Enjuone值接近1,11个问题的条件指数超过30。23个问题的方差膨胀系数(VIF)除4个问题外均小于10,容忍度除4个问题外均大于0.1。结论:沙特阿拉伯王国用于药物研究的生物统计分析人员的校正调查具有较高的信度和效度。药房的做法被适当地用于沙特阿拉伯进一步的未来研究。
{"title":"Reliability and Validity of Biostatical Analysis used for Pharmacy Research Questionnaire in Saudi Arabia","authors":"Y. Alomi, Ismail Hassan Amer Abu Rayah","doi":"10.5530/PTB.2020.6.18","DOIUrl":"https://doi.org/10.5530/PTB.2020.6.18","url":null,"abstract":"Phone no: +966504417712 E-mail: yalomi@gmail.com ABSTRACT Objectives: To declare reliability and validity of Biostatical Analysis used for Pharmacy Research Survey in Saudi Arabia. Methods: It is a cross-section survey developed by the authors and the research team. It’s based on the updated literature, national and international accreditation standards organizations. The Internal consistency, reliability through inter-rater reliability, item-item coloration, item-total coloration, Split half reliability (Gutmann’s λ6) and McDonald’s ω, Cronbach alpha. The validity contained of face content validity, construct validity through exploratory factorial analysis and confirmatory factor analysis. All analysis had been done through Statistical Package of Social Sciences (SPSS), Statistical Package of Social Sciences-Analysis of Moment Structures (SPSS-Amos) and Jeffrey’s Amazing Statistics Program (JASP). Results: A total of 209 pharmacists responded. The majority of responders were Saudi 185 (88.52%). The among responders were males [108 (61.77%)] and females [101 (48.33%)]. The three tests had been done with reliability of 31 questions. The completed responders (185) (mean ± SD) was 3.236 ± 0.326 and McDonald’s ω, Cronbach alpha and Gutmann’s λ6 were 0.980, 0.980 and 0.990, respectively with CI 95% (0.975-0.983) and inter-item coloration was 0.607, while the item-total coloration >0.53 and McDonald’s ω, Cronbach alpha and Gutmann’s λ6 value if deleted was >0.97. By using Exploratory Factor Analysis (EFA), the Kaiser-Meyer-Olkin Measure of sampling adequacy was 0.966 and Bartlett’s test of sphericity with approximate chi-square was <0.001. The commonalities extraction for all questions was >0.57, the related components were four of all 31 questions in four components as suggested. They were not confirmed by confirmatory with statistically significant (p<0.001) of the factor model, by factor analysis, by scree plot and pathway analysis and fit not with the original survey changed to 3 factor loading. The confirmatory factor index was (0.761), Tucker-Lewis Index (TLI) was (0.737), Goodness of fit index (GFI) was (0.844) and expected cross validation index (ECVI) (9.029). The collinearity of 23 questions was autocorrelation (2.609e -5) with not statistically significant (p=0.951). The majority of 23 question had Enjuone value close to number 1, while 11 questions had condition index more than 30. All of the 23 questions had The Variance inflation factor (VIF) less than 10 except four questions and had tolerance more than 0.1 except four questions. Conclusion: The reliability and validity related to the corrected survey of biostatistics analysts used in pharmaceutical research in the Kingdom of Saudi Arabia were high. The pharmacy practice was properly used in further future research in Saudi Arabia.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"309 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127567548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Reliability for Pharmacy Projects and Research: A New Initiative in the Kingdom of Saudi Arabia 药学项目和研究的可靠性:沙特阿拉伯王国的一项新倡议
Pub Date : 2020-06-04 DOI: 10.5530/PTB.2020.6.14
Y. Alomi
Phone no: +966504417712 E-mail: yalomi@gmail.com ABSTRACT Objectives: To declare reliability for pharmacy projects and research used in the pharmacy practice in Saudi Arabia. Methods: It is a new initiative project reliability for pharmacy projects and research programs. The projects drove international reliability guidelines and the global business model, pharmacy project guidelines project management institution guidelines of a new project. The initial plan is written through project management professionals and consisted of several parts, including the initial phase, the planning phase, the execution phase and the monitoring and controlling phase. Results: The reliability of pharmacy projects and research services that defined vision, mission and goals. The services had multiple benefits, including clinical and economical, on the healthcare system, as described in the review-the continuation of the services assured by risk management elements description. Moreover, the monitoring and controlling of the projects as illustrated. The transition to operation project though the closing project stage shown in the analysis. Conclusion: The reliability of pharmacy projects and research services is a new initiative project in pharmacy practice. There various tools of authenticity can be started implemented during pharmacy data collection; it is highly recommended in the Kingdom of Saudi Arabia.
摘要目的:申报沙特阿拉伯药学项目和研究在药学实践中的可靠性。方法:对药学项目和科研项目进行可靠性评价。该项目推动了国际可靠性指南和全球商业模式、药学项目指南项目管理机构指南的新项目。初始计划由项目管理专业人员撰写,由初始阶段、计划阶段、执行阶段和监控阶段等几个部分组成。结果:明确愿景、使命和目标的药学项目和研究服务的可靠性。正如审查中所描述的那样,这些服务对医疗保健系统有多种好处,包括临床和经济上的好处——风险管理要素描述确保了服务的延续。此外,还说明了项目的监测和控制。在分析中,通过项目收尾阶段向运营项目过渡。结论:药学项目与科研服务的可靠性是药学实践中一项新的创新项目。在药房数据收集过程中,可以启动实施各种真实性工具;在沙特阿拉伯王国强烈推荐。
{"title":"Reliability for Pharmacy Projects and Research: A New Initiative in the Kingdom of Saudi Arabia","authors":"Y. Alomi","doi":"10.5530/PTB.2020.6.14","DOIUrl":"https://doi.org/10.5530/PTB.2020.6.14","url":null,"abstract":"Phone no: +966504417712 E-mail: yalomi@gmail.com ABSTRACT Objectives: To declare reliability for pharmacy projects and research used in the pharmacy practice in Saudi Arabia. Methods: It is a new initiative project reliability for pharmacy projects and research programs. The projects drove international reliability guidelines and the global business model, pharmacy project guidelines project management institution guidelines of a new project. The initial plan is written through project management professionals and consisted of several parts, including the initial phase, the planning phase, the execution phase and the monitoring and controlling phase. Results: The reliability of pharmacy projects and research services that defined vision, mission and goals. The services had multiple benefits, including clinical and economical, on the healthcare system, as described in the review-the continuation of the services assured by risk management elements description. Moreover, the monitoring and controlling of the projects as illustrated. The transition to operation project though the closing project stage shown in the analysis. Conclusion: The reliability of pharmacy projects and research services is a new initiative project in pharmacy practice. There various tools of authenticity can be started implemented during pharmacy data collection; it is highly recommended in the Kingdom of Saudi Arabia.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114942996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability and Validity of Pharmacy Research Proposal Questionnaire in Saudi Arabia 沙特阿拉伯药学研究计划问卷的信度和效度
Pub Date : 2020-03-14 DOI: 10.5530/ptb.2020.6.6
Yousef Ahmed Alomi, A. Sadeq
Phone no: +966504417712 E-mail: yalomi@gmail.com ABSTRACT Objectives: To explore reliability and validity of pharmacy research proposal survey in the Kingdom of Saudi Arabia. Methods: It is a cross-section survey developed by the authors and the researcher team. It’s based on the updated literature, national and international accreditation standards organizations. The internal consistency reliability through, inter-rater reliability, item-item coloration, item-total coloration, split half reliability (Gutmann’s λ6), McDonald’s ω and Cronbach alpha. The validity consisted of face content validity, construct validity through exploratory factorial analysis and confirmatory factor analysis. All analysis had been done through Statistical Package of Social Sciences (SPSS), Statistical Package of Social Sciences-Analysis of Moment Structures (SPSS-Amos) and Jeffrey’s Amazing Statistics Program (JASP) Results: A total of 209 pharmacists responded. The majority of responders were Saudi 185 (88.52%). The among responders were males 108 (61.77%) and females 101 (48.33%). The three tests had been done of reliability of 17 questions of responders (204). The tests mean±SD was 3.788 ± 0.163, McDonald’s ω, Cronbach alpha and Gutmann’s λ6 were 0.975, 0.975 and 0.987, respectively and inter-item coloration was 0.705. The item-total coloration >0.7, McDonald’s ω, Cronbach alpha and Gutmann’s λ6 value if deleted was >0.97. By using Exploratory Factor Analysis (EFA), the Kaiser-Meyer-Olkin measure of sampling adequacy was 0.954 and Bartlett’s test of sphericity with approximate chi-square was <0.001. The commonalities extraction for all questions was >0.7, the related components were two with the rotated component matrix >0.7 of all 17 questions in components 1 and 2 as suggested. They were confirmed by confirmatory with statistically significant (p<0.001) of the factor model, by factor analysis, by scree plot, pathway analysis and fit with the original survey. The confirmatory factor index was 0.871, Tucker-Lewis Index (TLI) was 0.853, Goodness of fit index (GFI) was 0.912, Expected cross validation index (ECVI) was 4.299. The collinearity of 17 questions was auto-correlation was 0.058 with not statically significant (p=0.403). The majority of 17 questions had Enjuone value had close to number 1, while 7 questions only had condition index less than 30. Most of questions had the Variance inflation factor (VIF) less than 10 except 4 questions, while only 4 questions had tolerance less than 0.1. Conclusion: The reliability and validity of a survey about knowledge of pharmacy proposals in the Kingdom of Saudi Arabia were high. The pharmacist in pharmacy research practice can utilize the survey in the future.
摘要目的:探讨沙特阿拉伯王国药学研究计划调查的信度和效度。方法:由作者和课题组共同开展的横断面调查。它是基于最新的文献,国家和国际认证标准组织。通过内部一致性信度、量表间信度、项目-项目颜色、项目-总体颜色、分半信度(Gutmann 's λ6)、McDonald 's ω和Cronbach alpha进行测试。效度包括面部内容效度、建构效度(探索性因子分析)和验证性因子分析。所有分析均通过社会科学统计软件包(SPSS)、社会科学统计软件包-力矩结构分析(SPSS- amos)和杰弗里惊人统计程序(JASP)进行。结果:共有209名药剂师回复。应答者以沙特185人(88.52%)居多。应答者中男性108人(61.77%),女性101人(48.33%)。对应答者的17个问题(204个)进行了三次信度测试。检验均数±SD为3.788±0.163,McDonald 's ω、Cronbach α和Gutmann 's λ6分别为0.975、0.975和0.987,项目间显色为0.705。剔除后的项目总显色>0.7,McDonald’s ω、Cronbach alpha和Gutmann’s λ6值>0.97。经探索性因子分析(EFA), Kaiser-Meyer-Olkin抽样充分性测度为0.954,Bartlett球度近似卡方检验为0.7,相关分量为2,分量1和分量2中所有17个问题的旋转分量矩阵为>0.7。经因子模型的验证性(p<0.001)、因子分析、筛选图、通路分析及与原调查的拟合证实。验证性因子指数为0.871,Tucker-Lewis指数(TLI)为0.853,拟合优度指数(GFI)为0.912,期望交叉验证指数(ECVI)为4.299。17题共线性自相关为0.058,无统计学意义(p=0.403)。大多数问题的Enjuone值接近1,只有7个问题的条件指数小于30。除了4个问题外,大多数问题的方差膨胀系数(VIF)都小于10,只有4个问题的容忍度小于0.1。结论:沙特阿拉伯王国药学建议知识调查具有较高的信度和效度。药师在今后的药学研究实践中可以利用该调查。
{"title":"Reliability and Validity of Pharmacy Research Proposal Questionnaire in Saudi Arabia","authors":"Yousef Ahmed Alomi, A. Sadeq","doi":"10.5530/ptb.2020.6.6","DOIUrl":"https://doi.org/10.5530/ptb.2020.6.6","url":null,"abstract":"Phone no: +966504417712 E-mail: yalomi@gmail.com ABSTRACT Objectives: To explore reliability and validity of pharmacy research proposal survey in the Kingdom of Saudi Arabia. Methods: It is a cross-section survey developed by the authors and the researcher team. It’s based on the updated literature, national and international accreditation standards organizations. The internal consistency reliability through, inter-rater reliability, item-item coloration, item-total coloration, split half reliability (Gutmann’s λ6), McDonald’s ω and Cronbach alpha. The validity consisted of face content validity, construct validity through exploratory factorial analysis and confirmatory factor analysis. All analysis had been done through Statistical Package of Social Sciences (SPSS), Statistical Package of Social Sciences-Analysis of Moment Structures (SPSS-Amos) and Jeffrey’s Amazing Statistics Program (JASP) Results: A total of 209 pharmacists responded. The majority of responders were Saudi 185 (88.52%). The among responders were males 108 (61.77%) and females 101 (48.33%). The three tests had been done of reliability of 17 questions of responders (204). The tests mean±SD was 3.788 ± 0.163, McDonald’s ω, Cronbach alpha and Gutmann’s λ6 were 0.975, 0.975 and 0.987, respectively and inter-item coloration was 0.705. The item-total coloration >0.7, McDonald’s ω, Cronbach alpha and Gutmann’s λ6 value if deleted was >0.97. By using Exploratory Factor Analysis (EFA), the Kaiser-Meyer-Olkin measure of sampling adequacy was 0.954 and Bartlett’s test of sphericity with approximate chi-square was <0.001. The commonalities extraction for all questions was >0.7, the related components were two with the rotated component matrix >0.7 of all 17 questions in components 1 and 2 as suggested. They were confirmed by confirmatory with statistically significant (p<0.001) of the factor model, by factor analysis, by scree plot, pathway analysis and fit with the original survey. The confirmatory factor index was 0.871, Tucker-Lewis Index (TLI) was 0.853, Goodness of fit index (GFI) was 0.912, Expected cross validation index (ECVI) was 4.299. The collinearity of 17 questions was auto-correlation was 0.058 with not statically significant (p=0.403). The majority of 17 questions had Enjuone value had close to number 1, while 7 questions only had condition index less than 30. Most of questions had the Variance inflation factor (VIF) less than 10 except 4 questions, while only 4 questions had tolerance less than 0.1. Conclusion: The reliability and validity of a survey about knowledge of pharmacy proposals in the Kingdom of Saudi Arabia were high. The pharmacist in pharmacy research practice can utilize the survey in the future.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126963729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost Analysis of Neonatal Drug Distribution Services at Ministry of Health in Saudi Arabia 沙特阿拉伯卫生部新生儿药品配送服务成本分析
Pub Date : 2019-09-09 DOI: 10.5530/ptb.2019.5.32
Y. Alomi, M. Alhadab, Tahani Alotaibi, Awatif Faraj Alshammari, Nouf Alhaze
Yousef Ahmed Alomi* , The former General Manager of General Administration of Pharmaceutical Care, The former Head, National Clinical Pharmacy and Pharmacy Practice. The former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Malika Alhadab, Head, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Tahani Alotaibi, Supervisor, Inpatient Pharmacy, Pharmacy Services, Alyamma Hopsital, Ministry of Health, Riyadh, SAUDI ARABIA. Awatif Faraj Alshammari, Supervisor, IV admixture, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Nouf Alhaze, Supervisor, Medication safety officer, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA.
优素福·艾哈迈德·阿洛米*,原药政总局总经理,原国家临床药学与药学实践司司长。沙特阿拉伯利雅得卫生部药品研发管理局前局长。Malika Alhadab,沙特阿拉伯利雅得卫生部Alyamma医院药房服务主任。Tahani Alotaibi,沙特阿拉伯利雅得卫生部Alyamma医院药房服务住院药房主管。Awatif Faraj Alshammari,沙特阿拉伯利雅得卫生部Alyamma医院药房服务部静脉制剂主管。努夫·阿尔哈兹,沙特阿拉伯利雅得卫生部阿利亚马医院药房服务处药物安全官员主管。
{"title":"Cost Analysis of Neonatal Drug Distribution Services at Ministry of Health in Saudi Arabia","authors":"Y. Alomi, M. Alhadab, Tahani Alotaibi, Awatif Faraj Alshammari, Nouf Alhaze","doi":"10.5530/ptb.2019.5.32","DOIUrl":"https://doi.org/10.5530/ptb.2019.5.32","url":null,"abstract":"Yousef Ahmed Alomi* , The former General Manager of General Administration of Pharmaceutical Care, The former Head, National Clinical Pharmacy and Pharmacy Practice. The former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Malika Alhadab, Head, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Tahani Alotaibi, Supervisor, Inpatient Pharmacy, Pharmacy Services, Alyamma Hopsital, Ministry of Health, Riyadh, SAUDI ARABIA. Awatif Faraj Alshammari, Supervisor, IV admixture, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Nouf Alhaze, Supervisor, Medication safety officer, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116917155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost Analysis of Delivery Adult Medication Therapy Services at Ministry of Health in Saudi Arabia 沙特阿拉伯卫生部提供成人药物治疗服务的成本分析
Pub Date : 2019-09-09 DOI: 10.5530/ptb.2019.5.28
Y. Alomi, M. Alhadab, Tahani Alotaibi
Yousef Ahmed Alomi* , The former General Manager of General Administration of Pharmaceutical Care, The former Head, National Clinical Pharmacy and Pharmacy Practice. The former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Malika Alhadab, Head, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Tahani Alotaibi, Supervisor, Inpatient Pharmacy, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA.
优素福·艾哈迈德·阿洛米*,原药政总局总经理,原国家临床药学与药学实践司司长。沙特阿拉伯利雅得卫生部药品研发管理局前局长。Malika Alhadab,沙特阿拉伯利雅得卫生部Alyamma医院药房服务主任。Tahani Alotaibi,沙特阿拉伯利雅得卫生部阿Alyamma医院药房服务部住院药房主管。
{"title":"Cost Analysis of Delivery Adult Medication Therapy Services at Ministry of Health in Saudi Arabia","authors":"Y. Alomi, M. Alhadab, Tahani Alotaibi","doi":"10.5530/ptb.2019.5.28","DOIUrl":"https://doi.org/10.5530/ptb.2019.5.28","url":null,"abstract":"Yousef Ahmed Alomi* , The former General Manager of General Administration of Pharmaceutical Care, The former Head, National Clinical Pharmacy and Pharmacy Practice. The former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Malika Alhadab, Head, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Tahani Alotaibi, Supervisor, Inpatient Pharmacy, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"67 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121869978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Cost of Pediatrics Drug Therapy Services at Ministry of Health in Saudi Arabia 沙特阿拉伯卫生部儿科药物治疗服务费用
Pub Date : 2019-09-09 DOI: 10.5530/ptb.2019.5.30
Y. Alomi, M. Alhadab, Tahani Alotaibi, Awatif Faraj Alshammari, Nouf Alhaze
Yousef Ahmed Alomi* , The former General Manager of General Administration of Pharmaceutical Care, The former Head, National Clinical Pharmacy and Pharmacy Practice. The former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Malika Alhadab, Head, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Tahani Alotaibi, Supervisor, Inpatient Pharmacy, Pharmacy Services, Alyamma Hopsital, Ministry of Health, Riyadh, SAUDI ARABIA. Awatif Faraj Alshammari, Supervisor, IV admixture, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Nouf Alhaze, Supervisor, Medication safety officer, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA.
优素福·艾哈迈德·阿洛米*,原药政总局总经理,原国家临床药学与药学实践司司长。沙特阿拉伯利雅得卫生部药品研发管理局前局长。Malika Alhadab,沙特阿拉伯利雅得卫生部Alyamma医院药房服务主任。Tahani Alotaibi,沙特阿拉伯利雅得卫生部Alyamma医院药房服务住院药房主管。Awatif Faraj Alshammari,沙特阿拉伯利雅得卫生部Alyamma医院药房服务部静脉制剂主管。努夫·阿尔哈兹,沙特阿拉伯利雅得卫生部阿利亚马医院药房服务处药物安全官员主管。
{"title":"Cost of Pediatrics Drug Therapy Services at Ministry of Health in Saudi Arabia","authors":"Y. Alomi, M. Alhadab, Tahani Alotaibi, Awatif Faraj Alshammari, Nouf Alhaze","doi":"10.5530/ptb.2019.5.30","DOIUrl":"https://doi.org/10.5530/ptb.2019.5.30","url":null,"abstract":"Yousef Ahmed Alomi* , The former General Manager of General Administration of Pharmaceutical Care, The former Head, National Clinical Pharmacy and Pharmacy Practice. The former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Malika Alhadab, Head, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Tahani Alotaibi, Supervisor, Inpatient Pharmacy, Pharmacy Services, Alyamma Hopsital, Ministry of Health, Riyadh, SAUDI ARABIA. Awatif Faraj Alshammari, Supervisor, IV admixture, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA. Nouf Alhaze, Supervisor, Medication safety officer, Pharmacy Services, Alyamma Hospital, Ministry of Health, Riyadh, SAUDI ARABIA.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132878579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Economic Outcomes of Pharmacist Prescribing Total Parenteral Nutrition at Ministry of Health in Saudi Arabia 沙特阿拉伯卫生部药剂师开全肠外营养处方的经济效果
Pub Date : 2019-09-09 DOI: 10.5530/ptb.2019.5.35
Y. Alomi, M. A. Alanazi, F. Bahadig
Yousef Ahmed Alomi* , The Former General Manager of General Administration of Pharmaceutical Care. Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Mona Awad Alanazi, IV admixture and TPN units, Pharmacy services, Prince Mohammad Bin Abdulaziz Hospital Riyadh, SAUDI ARABIA. Faiz A. Bahadig, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, SAUDI ARABIA.
优素福·艾哈迈德·阿洛米*,原国家药品监督管理总局总经理。沙特阿拉伯利雅得卫生部药品研发管理局前局长,国家临床药学和药学实践前局长。Mona Awad Alanazi,静脉注射液和TPN单位,药房服务,沙特阿拉伯利雅得穆罕默德·本·阿卜杜勒阿齐兹王子医院。Faiz A. Bahadig,沙特阿拉伯国民警卫队吉达市阿卜杜勒-阿齐兹国王医院药学护理部信息学药剂师。
{"title":"Economic Outcomes of Pharmacist Prescribing Total Parenteral Nutrition at Ministry of Health in Saudi Arabia","authors":"Y. Alomi, M. A. Alanazi, F. Bahadig","doi":"10.5530/ptb.2019.5.35","DOIUrl":"https://doi.org/10.5530/ptb.2019.5.35","url":null,"abstract":"Yousef Ahmed Alomi* , The Former General Manager of General Administration of Pharmaceutical Care. Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Mona Awad Alanazi, IV admixture and TPN units, Pharmacy services, Prince Mohammad Bin Abdulaziz Hospital Riyadh, SAUDI ARABIA. Faiz A. Bahadig, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, SAUDI ARABIA.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"381 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126728778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Pharmacology, Toxicology and Biomedical Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1